我们的网站为什么显示成这样?

可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:

|本期目录/Table of Contents|

基于津液理论的食管癌治法探析(PDF)

《医学争鸣》[ISSN:1000-2790/CN:61-1060/R]

期数:
2019年05期
页码:
45-48
栏目:
学术探讨
出版日期:
2019-10-31

文章信息/Info

Title:
Discussion on treatment of esophageal cancer based on theory of body fluid
作者:
喻 凤1肖 冲1祝 捷1郑 川2严 然2由凤鸣3
(成都中医药大学:1临床医学院,2肿瘤研究所,3附属医院,四川 成都 610075)
Author(s):
YU Feng1 XIAO Chong1 ZHU Jie1 ZHENG Chuan2 YAN Ran2 YOU Fengming3
1 Clinical Medical School, 2 Cancer Research Institute, 3 Affiliated Hospital, Chengdu University of Traditional Chinese Medicine, Chengdu 610075, China
关键词:
噎膈津液食管腺癌食管鳞癌
Keywords:
cardiac spasm body fluid esophageal adenocarcinoma esophageal squamous cell carcinoma
分类号:
R2
DOI:
10.13276/j.issn.1674-8913.2019.05.012
文献标识码:
A
摘要:
痰、瘀、毒等为食管癌发生发展的主要病理因素,而这些因素产生的关键在于津液代谢障碍。食管 鳞癌,病机多兼火热,以津液耗散为主;食管腺癌,病机多痰瘀胶结,以燥湿相混为要。津、液在食管上皮的分 布差异以及鳞癌、腺癌的病机差别,使得食管癌的治法并非笼统的化痰、逐瘀、解毒。结合食管生理,立足津液 理论,分清痰瘀胶阻的态势以及病理分型的差异,调复津液,才是治疗食管癌的重点。
Abstract:
Phlegm, static blood and poison are the main pathological factors for the development of esophageal cancer, and the key to these factors is the metabolic disorder of the body fluid. Esophageal squamous cell carcinoma is mainly due to the dissipation of the body fluid mostly resulted from the hot pathogenic qi. Adenocarcinoma of the esophagus commonly presents the coexistence of dryness and wetness resulted from the intermingled phlegm and blood stasis. The treatment of esophageal cancer could not be simply defined as reducing phlegm, relieving stasis and neutralizing poison. It should be based on the physiological characteristics of the esophagus, the theory of body fluid, the degree of phlegm and blood stasis, and the difference of pathological types. The ultimate goal is to use various means to return the esophageal fluid into normal.

参考文献/References

[1] Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014[J]. CA Cancer J Clin, 2014, 64(1):9-29.
[2] Thomas P, Doddoli C, Lienne P, et al. Changing patterns and surgical results in adenocarcinoma of the oesophagus[J]. Br J Surg, 1997, 84(1):119-125.
[3] Cancer Genome Atlas Research Network, Analysis Working Group, Asan University, et al. Integrated genomic characterization of oesophageal carcinoma[J]. Nature, 2017,541(7636):169-175.
[4] 侯天将, 山 倩, 祝 捷, 等. 食管癌的中医治疗探索[J]. 四川中医, 2017, 35(3):30-32.
[5] 窦肇华. 人体解剖学和组织胚胎学[M]. 5版. 北京:人民 卫生出版社, 2004.
[6] 蒋树龙, 花宝金. 肿瘤发生发展痰瘀本质及其与肿瘤 微环境关系探析[J]. 中国中医基础医学杂志, 2015, 21(11):1417-1419.
[7] 孙桂芝. 孙桂芝实用中医肿瘤学[M]. 北京:中国中医药 出版社, 2009.
[8] Zeng H, Zheng R, Zhang S, et al. Esophageal cancer statistics in China, 2011: estimates based on 177 cancer registries[J]. Thorac Cancer, 2016, 7(2):232-237.
[9] Zhang YW. Epidemiology of esophageal cancer[J]. World J Gastroenterol, 2013, 19(34):5598-5606.
[10] 刘 玉. 河南食管癌高低发区1973—2012住院患者原发 性食管腺癌与食管鳞癌临床特征对比分析[D]. 郑州:郑 州大学, 2014.
[11] 祁友松, 邢燕玲. 试探Barrett食管的中医病机及辨证施 治[J]. 中医临床研究, 2014, 6(23):32-33.
[12] 张 玉, 张 青. 郁仁存治疗食管癌经验撷要[J]. 山东中 医杂志, 2018(11):909-911.
[13] 周 蕾, 李和根, 刘嘉湘. 刘嘉湘辨证治疗食管癌经 验[J]. 浙江中西医结合杂志, 2015(9):805-807.
[14] 李 晶, 史会娟. 以甘润濡养立法的启膈散治疗食管癌 概况[J]. 中国全科医学, 2015, 18(18):2198-2200.
[15] 夏孟蛟, 由凤鸣, 郑 川, 等. 论风药治肿瘤[J]. 中医杂志, 2017, 58(2):115-118.

备注/Memo

备注/Memo:
基金项目:四川省科技厅项目(2018SZ0089);成都中医药大学基金(ZRQN1729)
通信作者:由凤鸣。Tel:18908000398,E-mail:fengmingyou@hotmal.com
作者简介:喻 凤。硕士生(导师由凤鸣)。研究方向:中医药防治肿瘤病证的临床与实验研究。Tel:18215530911,E-mail:Y0108F@qq.com
更新日期/Last Update: 2019-10-31